Detalles de la búsqueda
1.
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.
Ann Oncol
; 35(5): 437-447, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369013
2.
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis.
Ann Oncol
; 34(2): 173-185, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414192
3.
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer.
Ann Oncol
; 32(9): 1137-1147, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34139272
4.
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Ann Oncol
; 28(11): 2698-2706, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29045553
5.
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study.
Pharmacogenomics J
; 17(5): 435-440, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27241063
6.
Cost-effectiveness of cognitive remediation and supported employment for people with mental illness: a randomized controlled trial.
Psychol Med
; 47(1): 53-65, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27654902
7.
Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin.
J Gen Virol
; 97(3): 561-570, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26675672
8.
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study).
Ann Oncol
; 27(1): 185-92, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26487585
9.
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
Ann Oncol
; 26(7): 1401-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25908605
10.
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study).
Ann Oncol
; 26(10): 2066-72, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26153496
11.
Leptin improves fatty liver independently of insulin sensitization and appetite suppression in hepatocyte-specific Pten-deficient mice with insulin hypersensitivity.
Horm Metab Res
; 47(3): 168-75, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25415231
12.
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.
Transpl Infect Dis
; 17(6): 810-5, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26354293
13.
Genomic best linear unbiased prediction method reflecting the degree of linkage disequilibrium.
J Anim Breed Genet
; 132(5): 357-65, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25866073
14.
Life history and reproductive ecology of the endangered Itasenpara bitterling Acheilognathus longipinnis (Cyprinidae) in the Himi region, central Japan.
J Fish Biol
; 87(3): 616-33, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26255608
15.
Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector.
Gene Ther
; 21(8): 775-84, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942630
16.
Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM.
ESMO Open
; 9(4): 102975, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520847
17.
Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.
Br J Cancer
; 109(3): 538-44, 2013 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23860537
18.
Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results.
ESMO Open
; 8(4): 101580, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390764
19.
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients.
ESMO Open
; 7(1): 100394, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158207
20.
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer.
ESMO Open
; 7(4): 100527, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35843080